Type I interferons directly down-regulate BCL-6 in primary and transformed germinal center B cells: Differential regulation in B cell lines derived from endemic or sporadic Burkitt’s lymphoma-Reference-Cited by-同舟云学术

Type I interferons directly down-regulate BCL-6 in primary and transformed germinal center B cells: Differential regulation in B cell lines derived from endemic or sporadic Burkitt’s lymphoma

Published:2012-03 Issue:3 Volume:57 Page:360-371
ISSN:1043-4666
Container-title:Cytokine
language:en
Short-container-title:Cytokine

Author:

Salamon Daniel,Adori Monika,He Minghui,Bönelt Peter,Severinson Eva,Kis Lorand L.,Wu Liang,Ujvari Dorina,Leveau Benjamin,Nagy Noemi,Klein George,Klein Eva

Publisher

Elsevier BV

Subject

Molecular Biology,Hematology,Biochemistry,Immunology,Immunology and Allergy

Reference60 articles.

1. Germinal centres: role in B-cell physiology and malignancy;Klein;Nat Rev Immunol,2008

2. BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis;Basso;Adv Immunol,2010

3. BCL6 is critical for the development of a diverse primary B cell repertoire;Duy;J Exp Med,2010

4. Control of inflammation, cytokine expression, and germinal center formation by BCL-6;Dent;Science,1997

5. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation;Ye;Nat Genet,1997

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endogenous Retrovirus Elements Are Co-Expressed with IFN Stimulation Genes in the JAK–STAT Pathway;Viruses;2022-12-24

2. S-Phase Kinase-Associated Protein-2 and Nuclear Factor-kappa Beta as Molecular Targets of Oral Burkitt’s Lymphoma Cell Induced by Quinolinone Derivate-Vesnarinone;Current Signal Transduction Therapy;2020-12-01

3. Chronic simian immunodeficiency virus infection is associated with contrasting phenotypes of dysfunctional Bcl6+germinal center B cells or Bcl6−Bcl2+non-germinal center B cells;Journal of Cellular and Molecular Medicine;2018-09-06

4. Identification of new type I interferon-stimulated genes and investigation of their involvement in IFN-β activation;Protein & Cell;2018-02-09

5. Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapy;International Journal of Oncology;2015-09-16